however, close monitoring for gastrointestinal adverse events is warranted in cirrhotic patients, who may have reduced tolerance
It is not approved for therapeutic use in humans, and no large-scale clinical trials have been conducted to evaluate its safety or efficacy as a medication
Benefits may reverse if the medication is stopped, often leading to weight regain and blood sugar spikes meaning these are not short-term interventions for most people who take them
Type-2 diabetes, obesity, and heart disease are the leaders in morbidity, disability, and mortality worldwide
These assessments ensure that beneficial metabolic effects persist and no adverse metabolic changes emerge
While there are savings programs available for both medications, the high price tag can put them out of reach for many folks who need treatment